First National Bank of Omaha’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.72M | Sell |
97,734
-6,910
| -7% | -$184K | 0.08% | 235 |
|
|
2025
Q4 | $2.61M | Buy |
104,644
+64,496
| +161% | +$1.63M | 0.08% | 237 |
|
|
2025
Q3 | $1.02M | Sell |
40,148
-270
| -0.7% | -$6.66K | 0.06% | 224 |
|
|
2025
Q2 | $980K | Hold |
40,418
| – | – | 0.06% | 222 |
|
|
2025
Q1 | $1.02M | Sell |
40,418
-1,627
| -4% | -$42.6K | 0.07% | 220 |
|
|
2024
Q4 | $1.12M | Sell |
42,045
-5,875
| -12% | -$159K | 0.07% | 215 |
|
|
2024
Q3 | $1.39M | Sell |
47,920
-3,960
| -8% | -$116K | 0.09% | 205 |
|
|
2024
Q2 | $1.45M | Buy |
51,880
+11,462
| +28% | +$316K | 0.1% | 198 |
|
|
2024
Q1 | $1.02M | Sell |
40,418
-18,997
| -32% | -$527K | 0.07% | 220 |
|
|
2023
Q4 | $1.71M | Sell |
59,415
-6,400
| -10% | -$193K | 0.11% | 196 |
|
|
2023
Q3 | $2.18M | Sell |
65,815
-310
| -0.5% | -$11K | 0.14% | 171 |
|
|
2023
Q2 | $2.43M | Sell |
66,125
-3,203
| -5% | -$125K | 0.14% | 167 |
|
|
2023
Q1 | $2.83M | Sell |
69,328
-3,093
| -4% | -$134K | 0.17% | 150 |
|
|
2022
Q4 | $3.71M | Sell |
72,421
-5,160
| -7% | -$247K | 0.23% | 136 |
|
|
2022
Q3 | $3.4M | Sell |
77,581
-3,361
| -4% | -$163K | 0.22% | 138 |
|
|
2022
Q2 | $4.24M | Sell |
80,942
-843
| -1% | -$43K | 0.26% | 122 |
|
|
2022
Q1 | $4.23M | Sell |
81,785
-2,795
| -3% | -$145K | 0.22% | 135 |
|
|
2021
Q4 | $4.99M | Sell |
84,580
-16,401
| -16% | -$813K | 0.24% | 131 |
|
|
2021
Q3 | $4.34M | Sell |
100,981
-5,617
| -5% | -$249K | 0.22% | 140 |
|
|
2021
Q2 | $3.86M | Hold |
106,598
| – | – | 0.2% | 144 |
|
|
2021
Q1 | $3.86M | Sell |
106,598
-9,011
| -8% | -$320K | 0.2% | 144 |
|
|
2020
Q4 | $4.25M | Sell |
115,609
-12,982
| -10% | -$476K | 0.23% | 133 |
|
|
2020
Q3 | $4.48M | Sell |
128,591
-19,837
| -13% | -$695K | 0.28% | 117 |
|
|
2020
Q2 | $4.6M | Sell |
148,428
-90,531
| -38% | -$3.08M | 0.31% | 110 |
|
|
2020
Q1 | $7.4M | Sell |
238,959
-55,205
| -19% | -$1.88M | 0.58% | 52 |
|
|
2019
Q4 | $10.9M | Sell |
294,164
-17,032
| -5% | -$607K | 0.66% | 41 |
|
|
2019
Q3 | $10.6M | Buy |
311,196
+750
| +0.2% | +$27.3K | 0.69% | 41 |
|
|
2019
Q2 | $12.8M | Buy |
310,446
+2,566
| +0.8% | +$102K | 0.83% | 26 |
|
|
2019
Q1 | $12.4M | Sell |
307,880
-2,433
| -0.8% | -$97.4K | 0.85% | 27 |
|
|
2018
Q4 | $12.9M | Buy |
310,313
+2,526
| +0.8% | +$105K | 0.97% | 17 |
|
|
2018
Q3 | $12.9M | Sell |
307,787
-3,814
| -1% | -$147K | 0.72% | 25 |
|
|
2018
Q2 | $10.7M | Buy |
311,601
+1,348
| +0.4% | +$46.1K | 0.63% | 33 |
|
|
2018
Q1 | $10.4M | Buy |
310,253
+122
| +0% | +$4.19K | 0.62% | 36 |
|
|
2017
Q4 | $10.7M | Buy |
310,131
+8,238
| +3% | +$281K | 0.62% | 37 |
|
|
2017
Q3 | $10.2M | Sell |
301,893
-4,752
| -2% | -$153K | 0.63% | 39 |
|
|
2017
Q2 | $9.77M | Sell |
306,645
-4,533
| -1% | -$143K | 0.61% | 40 |
|
|
2017
Q1 | $10.1M | Buy |
311,178
+33,720
| +12% | +$1.06M | 0.61% | 38 |
|
|
2016
Q4 | $8.55M | Buy |
277,458
+6,206
| +2% | +$189K | 0.53% | 55 |
|
|
2016
Q3 | $8.72M | Buy |
271,252
+1,866
| +0.7% | +$62.4K | 0.64% | 42 |
|
|
2016
Q2 | $9M | Buy |
269,386
+136,803
| +103% | +$4.37M | 0.67% | 43 |
|
|
2016
Q1 | $3.73M | Buy |
132,583
+7,173
| +6% | +$205K | 0.28% | 121 |
|
|
2015
Q4 | $3.84K | Buy |
125,410
+9,183
| +8% | +$289K | 0.27% | 121 |
|
|
2015
Q3 | $3.46K | Buy |
116,227
+4,542
| +4% | +$146K | 0.26% | 125 |
|
|
2015
Q2 | $3.6K | Hold |
111,685
| – | – | 0.25% | 127 |
|
|
2015
Q1 | $3.6K | Buy |
111,685
+7,923
| +8% | +$252K | 0.25% | 127 |
|
|
2014
Q4 | $3.07M | Sell |
103,762
-4,893
| -5% | -$140K | 0.21% | 136 |
|
|
2014
Q3 | $3.05M | Buy |
108,655
+1,186
| +1% | +$33.3K | 0.22% | 136 |
|
|
2014
Q2 | $3.03M | Buy |
107,469
+3,262
| +3% | +$93K | 0.21% | 139 |
|
|
2014
Q1 | $3.17M | Buy |
104,207
+50,661
| +95% | +$1.51M | 0.23% | 135 |
|
|
2013
Q4 | $1.56M | Sell |
53,546
-6,788
| -11% | -$198K | 0.12% | 173 |
|
|
2013
Q3 | $1.64M | Sell |
60,334
-2,627
| -4% | -$71.5K | 0.14% | 157 |
|
|
2013
Q2 | $1.67K | Buy |
+62,961
| New | +$1.74M | 0.14% | 156 |
|
Other funds holding PFE
VCM
VPM
First National Bank of Omaha's PFE Position: Q1 2026 in Review
First National Bank of Omaha reduced its Pfizer (PFE) stake by 6.6% in Q1 2026, selling an estimated $184K and leaving 97,734 shares worth $2.72M. The position accounts for 0.08% of the portfolio, ranked #235.
First National Bank of Omaha first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.9M in Q3 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- First National Bank of Omaha held 97,734 shares of Pfizer worth $2.72M as of Q1 2026.
- First National Bank of Omaha sold 6,910 Pfizer shares in Q1 2026, an estimated $184K.
- Pfizer made up 0.08% of First National Bank of Omaha's portfolio in Q1 2026, its #235 holding.
- First National Bank of Omaha first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- First National Bank of Omaha's Pfizer position peaked at $12.9M in Q3 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on First National Bank of Omaha's 13F filing for Q1 2026, filed 11 May 2026.